Enabling highly efficient, easy to manufacture antibody-drug conjugates (ADCs) with low side-effects

• Unité de recherche: INNOSUISSE
• Numéro de projet: 28170.1 PFLS-LS
• Titre du projet anglais: Enabling highly efficient, easy to manufacture antibody-drug conjugates (ADCs) with low side-effects

Description succincte (Allemand)

Enabling highly efficient, easy to manufacture antibody-drug conjugates (ADCs) with low side-effects

Description succincte (Anglais)

Enabling highly efficient, easy to manufacture antibody-drug conjugates (ADCs) with low side-effects

Résumé des résultats (Abstract) (Allemand)

In this proof-of-concept study we aim to evaluate the in-vitro and in-vivo properties of antibody-drug conjugates (ADCs) that are generated by a new site-specific conjugation method to native antibodies. Our technology aims to enable highly efficient, easy to manufacture ADCs with low side-effects.

Résumé des résultats (Abstract) (Anglais)